Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinosmart Group is a China-based pharmaceutical service provider that specializes in the research, development, and manufacturing of high-end pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Operating as a Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO), the company provides a wide range of services including custom synthesis, process development, and large-scale production for the global life sciences industry. Sinosmart's expertise lies in complex organic synthesis, particularly in the production of heterocyclic compounds and specialized building blocks for drug discovery. The company maintains integrated R&D centers and manufacturing facilities that adhere to international quality standards, serving clients in the pharmaceutical, biotech, and fine chemical sectors. Their business model focuses on accelerating the drug development timeline by providing reliable chemical supply chain solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinosmart Group.